Legacy Capital Wealth Partners LLC Has $234,000 Position in Integer Holdings Co. (NYSE:ITGR)

Legacy Capital Wealth Partners LLC cut its stake in Integer Holdings Co. (NYSE:ITGR) by 52.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,762 shares of the medical equipment provider’s stock after selling 1,926 shares during the period. Legacy Capital Wealth Partners LLC’s holdings in Integer were worth $234,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in ITGR. Eagle Asset Management Inc. bought a new stake in Integer in the third quarter valued at approximately $14,403,000. Laurus Investment Counsel Inc. bought a new stake in Integer in the fourth quarter valued at approximately $5,422,000. Bamco Inc. NY boosted its holdings in Integer by 17.4% in the third quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock valued at $33,069,000 after acquiring an additional 37,700 shares during the last quarter. Jane Street Group LLC boosted its holdings in Integer by 23.3% in the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after acquiring an additional 28,572 shares during the last quarter. Finally, Point72 DIFC Ltd bought a new position in shares of Integer during the 3rd quarter worth approximately $2,977,000. 99.29% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. KeyCorp increased their price target on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Piper Sandler restated an “overweight” rating and set a $140.00 price target (up from $125.00) on shares of Integer in a report on Friday, October 25th. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Finally, Benchmark increased their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $146.56.

Integer Price Performance

Shares of ITGR opened at $140.94 on Tuesday. Integer Holdings Co. has a 12-month low of $94.56 and a 12-month high of $146.36. The business’s fifty day moving average is $137.84 and its 200 day moving average is $131.82. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock has a market cap of $4.73 billion, a P/E ratio of 43.50, a P/E/G ratio of 1.79 and a beta of 1.13.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.